Could Heartburn Meds Lead to Drug-Resistant Germs?
The findings do not prove that PPIs -- which include popular brands such as Prilosec (omeprazole), Prevacid (lansoprazole) and Nexium (esomeprazole) -- are the cause, experts said.         But they are the latest to raise safety questions about the top-selling prescription and over-the-counter medicines. (Source: WebMD Health)
Source: WebMD Health - February 25, 2020 Category: Consumer Health News Source Type: news

Talicia (Omeprazole Magnesium, Amoxicillin and Rifabutin Delayed-release Capsules) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 13, 2019 Category: Drugs & Pharmacology Source Type: news

Class 2 medicines recall: Omeprazole 40 mg powder for solution for infusion
Sandoz Limited is recalling one batch of omeprazole 40 mg powder for solution for infusion due to the occurrence of degradation in some vials, resulting in green discoloration of the powder in the via (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - November 11, 2019 Category: Drugs & Pharmacology Source Type: news

FDA Approves Talicia (omeprazole magnesium, amoxicillin and rifabutin) for the Treatment of H. pylori Infection in Adults
TEL-AVIV, Israel and RALEIGH, N.C., Nov. 04, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the“Company”), a specialty biopharmaceutical company primarily focused... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - November 4, 2019 Category: Drugs & Pharmacology Source Type: news

FDA OKs First Rifabutin-Based H Pylori Therapy Talicia FDA OKs First Rifabutin-Based H Pylori Therapy Talicia
Talicia combines omeprazole, amoxicillin, and rifabutin and is designed to address growing bacterial resistance to standard clarithromycin-based H pylori therapy.FDA Approvals (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - November 4, 2019 Category: Intensive Care Tags: Infectious Diseases News Alert Source Type: news

FDA says Pepcid and Prilosec do NOT contain carcinogen in Zantac
The Food and Drug Administration on Wednesday told Americans that Prilosec, Pepcid and other alternatives are free of NDMA found in Zantac - but they have other risks. (Source: the Mail online | Health)
Source: the Mail online | Health - October 24, 2019 Category: Consumer Health News Source Type: news

AstraZeneca divests rights for Losec to Cheplapharm
AstraZeneca has agreed to sell the global commercial rights, excluding China, Japan, the US and Mexico, for Losec (omeprazole) and associated brands to Cheplapharm Arzneimittel GmbH (Cheplapharm). The divestment includes medicines containing omeprazole marketed by AstraZeneca or its collaborators under the Acimax, Antra, Mepral, Mopral, Omepral and Zoltum medicine names. (Source: World Pharma News)
Source: World Pharma News - October 1, 2019 Category: Pharmaceuticals Tags: Featured AstraZeneca Business and Industry Source Type: news

CVS Halts Sale of Heartburn Treatment Zantac as FDA Warns of Contaminants
CVS has halted sales of popular heartburn treatment Zantac and its generic store brand after warnings by U.S. health regulators. It’s the latest precautionary move by retailers and manufacturers after the U.S. Food and Drug Administration recently warned consumers about a potentially dangerous contaminant in prescription and over-the-counter versions of Zantac. In its announcement this weekend, CVS said customers who bought Zantac products can return them for a refund. The retailer will continue to sell other heartburn medications. What’s the issue? In September, the FDA said it detected low levels of a probabl...
Source: TIME: Health - September 30, 2019 Category: Consumer Health News Authors: LINDA A. JOHNSON / AP Tags: Uncategorized medicine onetime Source Type: news

36% of proton pump inhibitor prescriptions for older adults may be unneeded
FINDINGSOne in eight older adults was prescribed proton pump inhibitor drugs, which are used to treat gastric ulcers or to prevent gastrointestinal bleeding in those taking blood thinners. About 36 percent of those prescriptions were potentially unnecessary, a study found, primarily because people took them far longer than the often-recommended eight weeks.BACKGROUNDOlder Americans frequently receive  low-value care, which is care that has no net benefit to the individual and has the potential to harm them. Low-value care contributes significantly to higher health costs. Most people are unaware of the potential toxici...
Source: UCLA Newsroom: Health Sciences - September 5, 2019 Category: Universities & Medical Training Source Type: news

Spanish Parents Sue After Acid Reflux Medication Mix Up Leaves Babies With ‘Abnormal’ Body Hair Growth
(MADRID) — Parents of babies and toddlers in Spain who have developed abnormal body hair plan to sue a pharmaceutical company that put a treatment for hair loss into packages meant for addressing acid reflux and other conditions. Spanish health authorities have blamed the Minoxidil mix-up on Farma-Química Sur. They say the well-known topical treatment was put in packaging that was supposed to contain a syrup with omeprazole, which is used for stomach problems. Spain’s Health Ministry has said at least 20 children from the age of a few weeks to two years have been affected. The mother of a 10-month old bo...
Source: TIME: Health - August 31, 2019 Category: Consumer Health News Authors: Associated Press Tags: Uncategorized onetime Spain Source Type: news

Medical News Today: What to know about omeprazole
This article looks at its uses, dosage, and side effects, as well as what to know before taking the medication. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 24, 2019 Category: Consumer Health News Tags: Acid Reflux / GERD Source Type: news

Low-Income Countries Pay Over 20 Times More for Generic Drugs
By Caley PigliucciUNITED NATIONS, Jun 21 2019 (IPS) A recently-released report by the Washington-based Center for Global Development (CGD) shows that generic drugs, like omeprazole (used to treat heartburn), can cost 20-30 times more in low and middle-income countries than in high-income countries. Rachel Silverman, a researcher with CGD who worked on the report, told IPS that “There is a lack of competition at the country level, even for basic, off-patent generic medicines. One firm can sometimes control 85% or more of the market share for specific drugs or therapy classes in some countries.” The report also...
Source: IPS Inter Press Service - Health - June 21, 2019 Category: International Medicine & Public Health Authors: Caley Pigliucci Tags: Aid Development & Aid Economy & Trade Global Headlines Health Population TerraViva United Nations Source Type: news

Digestive enzymes vs. omeprazole (Prilosec)
Title: Digestive enzymes vs. omeprazole (Prilosec)Category: MedicationsCreated: 6/19/2019 12:00:00 AMLast Editorial Review: 6/19/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - June 19, 2019 Category: Drugs & Pharmacology Source Type: news

Heartburn Drugs Can Lead to Fatal Heart or Kidney Disease
Proton pump inhibitors like Prevacid and Prilosec should be taken at low doses and for the shortest time possible. (Source: NYT Health)
Source: NYT Health - June 11, 2019 Category: Consumer Health News Authors: Nicholas Bakalar Tags: Heartburn Ulcers Kidneys Source Type: news

Carafate (sucralfate) vs. Prilosec (omeprazole)
Title: Carafate (sucralfate) vs. Prilosec (omeprazole)Category: MedicationsCreated: 6/7/2019 12:00:00 AMLast Editorial Review: 6/7/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - June 7, 2019 Category: Drugs & Pharmacology Source Type: news

Overuse of heartburn drugs linked to heart, kidney disease, cancer
Researchers have linked popular drugs like Prevacid, Prilosec, Nexium and other proton pump inhibitors to a higher risk of death by cardiovascular and chronic kidney disease, as well as upper gastrointestinal cancer. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 30, 2019 Category: Consumer Health News Source Type: news

Common acid reflux medications linked to increased kidney disease risk
(University of California - San Diego) Mining a large database of adverse reactions to medications, UC San Diego researchers found that people who took proton pump inhibitors (e.g., Prilosec, Nexium) for heartburn and acid reflux were more likely to experience kidney disease than people who took other forms of antacid. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 19, 2019 Category: International Medicine & Public Health Source Type: news

Dr Reddy's launches heartburn drug in US market
Dr Reddy's Laboratories said the combined market of Prilosec OTC and private label omeprazole OTC products had US retail sales of around $492 mn for the most recent 12 months ending in October 2018. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 11, 2018 Category: Pharmaceuticals Source Type: news

omeprazole (Prilosec, Zegerid)
Title: omeprazole (Prilosec, Zegerid)Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 11/6/2018 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - November 6, 2018 Category: Nutrition Source Type: news

No increased risk of lung infections among infants using popular anti-reflux medicines
(University of Otago) New University of Otago research shows infants using popular anti-reflux medicines like omeprazole are not at increased risk of pneumonia or other lower respiratory tract infections, contrary to findings from other international studies. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 18, 2018 Category: International Medicine & Public Health Source Type: news

Former P & G executive named CFO of pharmaceutical firm
Former Procter& Gamble executive Tim Hendrickson has been named chief financial officer of HLS Therapeutics Inc., a specialty pharmaceutical company. Hendrickson worked for the Cincinnati-based maker of consumer goods such as Prilosec OTC heartburn reliever (NYSE: PG) for more than 11 years, rising to finance leader in Canada for the subsidiary Procter& Gamble Pharmaceuticals Canada Inc. He worked in finance and business development for Procter& Gamble Pharmaceuticals Canada from 2003 to 2009, … (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 11, 2018 Category: Pharmaceuticals Authors: Barrett J. Brunsman Source Type: news

P & G open to more acquisitions, CFO says
Procter& Gamble chief financial officer Jon Moeller said Thursday morning that the company is open to more acquisitions, including in the over-the-counter health care space. Executives with the Cincinnati-based maker of consumer goods such as Prilosec OTC heartburn reliever (NYSE: PG) believe such acquisitions would pay off because of P&G ’s expertise in marketing and other areas. “OTC healthcare (is) very attractive from a margin standpoint, from a growth standpoint, from a demographic standpoint,… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 6, 2018 Category: American Health Authors: Barrett J. Brunsman Source Type: news

P & G clears hurdle to $4B acquisition
Procter& Gamble Co. today got the greenlight from the European Commission to acquire the consumer health care brands of Merck KGaA of Germany, a $4 billion deal that required a review under the European Union ’s merger regulation. The Cincinnati-based maker of consumer goods such as Prilosec OTC heartburn reliever (NYSE: PG) intends to scale up the company’s over-the-counter health care business, which accounts for $2 billion in revenue. “The commission concluded that the proposed transaction… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 28, 2018 Category: Pharmaceuticals Authors: Barrett J. Brunsman Source Type: news

P & G clears hurdle to $4B acquisition
Procter& Gamble Co. today got the greenlight from the European Commission to acquire the consumer health care brands of Merck KGaA of Germany, a $4 billion deal that required a review under the European Union ’s merger regulation. The Cincinnati-based maker of consumer goods such as Prilosec OTC heartburn reliever (NYSE: PG) intends to scale up the company’s over-the-counter health care business, which accounts for $2 billion in revenue. “The commission concluded that the proposed transaction… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 28, 2018 Category: Biotechnology Authors: Barrett J. Brunsman Source Type: news

Observation on therapeutic effect of combined acupuncture for stress gastric mucosal injury after traumatic brain injury - Sun Y, Ma T, Chen C, Zhang S.
OBJECTIVE: To observe the therapeutic effect of combined acupuncture combined with omeprazole on patients with craniocerebral trauma complicated with stress gastric mucosal injury. METHODS: Patients with stress gastric mucosal injury after cerebral... (Source: SafetyLit)
Source: SafetyLit - July 19, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Omeprazole Capsules (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - July 10, 2018 Category: Drugs & Pharmacology Source Type: news

Zydus gets USFDA nod to market drugs for stomach ailments
"Zydus Cadila has received the final approval from USFDA to market Omeprazole and Sodium bicarbonate capsules 20 mg/1100 mg (OTC)," the company said in a filing to BSE. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 17, 2018 Category: Pharmaceuticals Source Type: news

Proton Pump Inhibitors Not Tied to Hip Fractures in Alzheimer's Patients
WEDNESDAY, March 14, 2018 -- Long-term use of acid-blocking heartburn drugs, such as Nexium and Prilosec, does not increase the risk for hip fractures in people with Alzheimer's disease, a new study finds. These medications belong to a class of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 14, 2018 Category: General Medicine Source Type: news

DOUBLE your risk of stomach cancer with acid reflux drugs, study claims
(Natural News) A new study claims that you could double your risk of developing stomach cancer by mindlessly taking acid reflux drugs. The report stated that proton pump inhibitors (PPIs) greatly increase a person’s risk of having gastrointestinal tumors. Some of the known PPIs are Prilosec, Prevacid, and Protonix. The study showed data from 63,397 individually-monitored adults who... (Source: NaturalNews.com)
Source: NaturalNews.com - November 27, 2017 Category: Consumer Health News Source Type: news

Common Heartburn Meds Show Ties to Kidney Trouble
SATURDAY, Nov. 4, 2017 -- If you're one of the millions of Americans who takes one of a class of anti-reflux meds such as Nexium, Prilosec and Prevacid, take heed: These drugs have been linked to higher odds of kidney trouble. The study couldn't... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 4, 2017 Category: General Medicine Source Type: news

Popular Over-The-Counter Antacids Could Increase The Risk Of Stomach Cancer
This study was not able to prove that the medications lead to a higher risk of gastric cancer, it just suggested an association. They also studied conflicts with another recent study that suggested no increased risk of stomach cancer with these medications. That said, doctors and patients should exercise caution when using them over a long period of time.   (Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire)
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - November 2, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Healthwatch Local News Seen On WBZ-TV Syndicated Local Dr. Mallika Marshall Source Type: news

Acid reflux drugs could double your risk of stomach cancer
Researchers from the University of Hong Kong and University College London found that acid reflux medications, such as Prilosec, could double your risk of developing stomach cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - November 1, 2017 Category: Consumer Health News Source Type: news

Acid reflux drugs linked to increased stomach cancer risk
Conclusion PPIs are commonly used medicines for acid reflux. This may seem like alarming news for the many people in the UK who take them, but it's important to remember that the overall risk of stomach cancer is still very low. This study has several limitations that mean we should be cautious about the results: This type of study can't prove PPIs caused the increased risk of cancer. The increased risk could be down to other factors. Researchers were unable to adjust their figures to take account of some relevant confounding factors, such as alcohol and tobacco use, as these weren't routinely recorded. Almost all the pati...
Source: NHS News Feed - November 1, 2017 Category: Consumer Health News Tags: Cancer Source Type: news

Prilosec vs. Zantac
Title: Prilosec vs. ZantacCategory: MedicationsCreated: 11/1/2017 12:00:00 AMLast Editorial Review: 11/1/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - November 1, 2017 Category: Drugs & Pharmacology Source Type: news

Yosprala (Aspirin and Omeprazole Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 18, 2017 Category: Drugs & Pharmacology Source Type: news

Can You Develop a Tolerance for Prilosec?
Title: Can You Develop a Tolerance for Prilosec?Category: Doctor's& Expert's views on SymptomsCreated: 9/18/2017 12:00:00 AMLast Editorial Review: 9/18/2017 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - September 18, 2017 Category: Nutrition Source Type: news

Heartburn drugs like Nexium and Prilosec don't raise Alzheimer's risk: study
Widely used heartburn drugs, including Prilosec and Nexium, do not appear to increase Alzheimer's disease risk, according to a new study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 19, 2017 Category: Consumer Health News Source Type: news

Popular Heartburn Drugs Don't Raise Risk of Alzheimer's: Study
Researchers say proton pump inhibitors like Nexium or Prilosec not linked to dementia (Source: WebMD Health)
Source: WebMD Health - August 19, 2017 Category: Consumer Health News Source Type: news

Popular Heartburn Drugs Don't Raise Risk of Alzheimer's
Researchers say proton pump inhibitors like Nexium or Prilosec not linked to dementia Source: HealthDay Related MedlinePlus Pages: Alzheimer's Disease, Drug Safety, Heartburn (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - August 18, 2017 Category: Consumer Health News Source Type: news

Popular Heartburn Drugs Don't Raise Risk of Alzheimer's: Study
FRIDAY, Aug. 18, 2017 -- Widely used heartburn drugs called proton pump inhibitors do not appear to increase Alzheimer's disease risk, according to a new study. Prilosec, Nexium and Prevacid are commonly used proton pump inhibitors. Two previous... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 18, 2017 Category: General Medicine Source Type: news

Heartburn drugs linked to premature death
Conclusion This larger set of observational data finds that PPI drugs are associated with an increase in the risk of early death compared with either H2 blockers or no acid suppression drugs. This was the case for participants both with and without gastrointestinal problems. It also appears as though the longer the PPIs drugs are taken, the greater the risk of death. Considering that these drugs are widely used in the UK, these findings may cause concern. But the research has a number of important limitations: The study was conducted in a population of mostly white, older US male veterans, which might limit the abi...
Source: NHS News Feed - July 4, 2017 Category: Consumer Health News Tags: Medication Source Type: news

Some heartburn drugs linked with higher risk of death
Study looked at patients who'd taken proton pump inhibitors, or PPIs, including popular brands like Prilosec, Nexium and Prevacid (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - July 4, 2017 Category: Consumer Health News Source Type: news

Study: Heartburn meds could shorten life span
Popular heartburn medications like Nexium, Prilosec or Prevacid may increase your risk of early death when taken for extended periods, a new study suggests. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 4, 2017 Category: Consumer Health News Source Type: news

Can Your Heartburn Meds Shorten Your Life?
MONDAY, July 3, 2017 -- Popular heartburn medications like Nexium, Prilosec or Prevacid may increase your risk of early death when taken for extended periods, a new study suggests. Further, the longer you take these drugs, known as proton pump... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 3, 2017 Category: General Medicine Source Type: news

Zegerid (Omeprazole, Sodium Bicarbonate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 3, 2017 Category: Drugs & Pharmacology Source Type: news

Torax Medical touts preliminary results from Linx GERD study
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon‘s Torax Medical business today released results from the Caliber trial of its Linx system for treating gastro-esophageal reflux disease, touting quality of life improvements and reduction in reflux levels. The Linx system is an implant composed of interlinked titanium beads with magnetic cores that augments the esophageal sphincter’s barrier function to prevent reflux in patients with gastro-esophageal reflux disease, the company said. Data from the trial was presented at the Digestive Disease Week 2017 meeting in Chicago. The randomized, controlled, 150-patie...
Source: Mass Device - May 24, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Otolaryngology Ear, Nose & Throat Ethicon Johnson & Johnson Torax Medical Inc. Source Type: news

Prilosec (omeprazole) vs. Nexium (esomeprazole)
Title: Prilosec (omeprazole) vs. Nexium (esomeprazole)Category: MedicationsCreated: 3/30/2017 12:00:00 AMLast Editorial Review: 3/30/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - March 30, 2017 Category: Drugs & Pharmacology Source Type: news

Study Suggests Heartburn Meds-Superbug Infections Link
MONDAY, March 27, 2017 -- Patients who take certain heartburn medications may be more likely to suffer recurrent bouts of a common " superbug " infection, a new study suggests. Proton pump inhibitors, such as Prilosec, Prevacid and Nexium, or... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 27, 2017 Category: Journals (General) Source Type: news